Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuka Aizawa

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Brain Research|March 5, 2019
N-3 fatty acids modulate repeated stress-evoked pain chronicityFuka Aizawa, Shumpei Sato, Fumiyoshi Yamazaki, et al.
Multiple Sclerosis and Related Disorders|March 15, 2026
Bile acids as candidate therapies for multiple sclerosis: inverse signal analysis using the FDA adverse event reporting system and preclinical validationMizuho Asada, Fuka Aizawa, Takahisa Mikami, et al.
Cardiovascular Toxicology|February 19, 2025
Cardiovascular Toxicity Profile of Macrolides Investigated Using VigiBase Data: A Pharmacovigilance StudyYuki Kono, Takahiro Niimura, Mitsuhiro Goda, et al.
The Journal of Medical Investigation : JMI|May 12, 2024
The Association between PDE5 Inhibitors and Aneurysm/Arterial Dissection:A Pharmacovigilance Study Using WHO Safety DatabaseKoji Miyata, Yuki Izawa-Ishizawa, Takahiro Niimura, et al.
Clinical Therapeutics|October 13, 2021
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective StudyNaoto Okada, Yuki Izumi, Aki Nakamoto, et al.
Plos One|July 21, 2017
Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in miceKazuo Nakamoto, Fuka Aizawa, Kei Miyagi, et al.
JMIR Medical Education|March 3, 2026
Prescription Support Practice for Pharmacy Students: Pre-Post Educational Intervention StudyFuka Aizawa, Kenta Yagi, Tsukasa Higashionna, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2025
Unravelling the cardioprotective effects of calcitriol in Sunitinib-induced toxicity: A comprehensive in silico and in vitro studyYoshika Sakamoto, Takahiro Niimura, Mitsuhiro Goda, et al.
Expert Opinion on Drug Safety|July 25, 2025
Trends in the use of sodium-glucose cotransporter-2 inhibitors and characteristics of adverse event reporting in patients with heart failure in Japan: reports from the medical administration database and the adverse event reporting databaseKazuya Sato, Kei Kawada, Tomoaki Ishida, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combinationTakahiro Niimura, Mitsuhiro Goda, Koji Miyata, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Brain Research|March 5, 2019
N-3 fatty acids modulate repeated stress-evoked pain chronicityFuka Aizawa, Shumpei Sato, Fumiyoshi Yamazaki, et al.
Multiple Sclerosis and Related Disorders|March 15, 2026
Bile acids as candidate therapies for multiple sclerosis: inverse signal analysis using the FDA adverse event reporting system and preclinical validationMizuho Asada, Fuka Aizawa, Takahisa Mikami, et al.
Cardiovascular Toxicology|February 19, 2025
Cardiovascular Toxicity Profile of Macrolides Investigated Using VigiBase Data: A Pharmacovigilance StudyYuki Kono, Takahiro Niimura, Mitsuhiro Goda, et al.
The Journal of Medical Investigation : JMI|May 12, 2024
The Association between PDE5 Inhibitors and Aneurysm/Arterial Dissection:A Pharmacovigilance Study Using WHO Safety DatabaseKoji Miyata, Yuki Izawa-Ishizawa, Takahiro Niimura, et al.
Clinical Therapeutics|October 13, 2021
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective StudyNaoto Okada, Yuki Izumi, Aki Nakamoto, et al.
Plos One|July 21, 2017
Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in miceKazuo Nakamoto, Fuka Aizawa, Kei Miyagi, et al.
JMIR Medical Education|March 3, 2026
Prescription Support Practice for Pharmacy Students: Pre-Post Educational Intervention StudyFuka Aizawa, Kenta Yagi, Tsukasa Higashionna, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2025
Unravelling the cardioprotective effects of calcitriol in Sunitinib-induced toxicity: A comprehensive in silico and in vitro studyYoshika Sakamoto, Takahiro Niimura, Mitsuhiro Goda, et al.
Expert Opinion on Drug Safety|July 25, 2025
Trends in the use of sodium-glucose cotransporter-2 inhibitors and characteristics of adverse event reporting in patients with heart failure in Japan: reports from the medical administration database and the adverse event reporting databaseKazuya Sato, Kei Kawada, Tomoaki Ishida, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combinationTakahiro Niimura, Mitsuhiro Goda, Koji Miyata, et al.
Pageof 5